D&A
Merck & Co. D&A increased by 180.6% to $1.49B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 186.0%, from $522.00M to $1.49B. Over 4 years (FY 2021 to FY 2025), D&A shows an upward trend with a 17.9% CAGR.
Analysis
How to read this metric
Higher levels typically reflect significant historical capital expenditures or acquisitions that are now being expensed over time.
Detailed definition
This metric represents the non-cash accounting charges used to allocate the cost of tangible assets and intangible asset...
Peer comparison
Capital-intensive hardware manufacturers generally show higher D&A relative to revenue than pure-play software companies.
cf_depreciation_and_amortizationHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $353.00M | $399.00M | $430.00M | $421.00M | $474.00M | $499.00M | $430.00M | $448.00M | $426.00M | $452.00M | $502.00M | $511.00M | $518.00M | $553.00M | $522.00M | $502.00M | $518.00M | $532.00M | $1.49B |
| QoQ Change | — | +13.0% | +7.8% | -2.1% | +12.6% | +5.3% | -13.8% | +4.2% | -4.9% | +6.1% | +11.1% | +1.8% | +1.4% | +6.8% | -5.6% | -3.8% | +3.2% | +2.7% | +180.6% |
| YoY Change | — | — | — | — | +34.3% | +25.1% | +0.0% | +6.4% | -10.1% | -9.4% | +16.7% | +14.1% | +21.6% | +22.3% | +4.0% | -1.8% | +0.0% | -3.8% | +186.0% |
Business Segments
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Animal Healthsegment | $58.00M | $67.00M | $85.00M | $46.00M | $60.00M | $62.00M | $82.00M | $78.00M |
| Pharmaceuticalsegment | $1.00M | $1.00M | $1.00M | $2.00M | $1.00M | $1.00M | $1.00M | $2.00M |
| Total | $511.00M | $518.00M | $553.00M | $522.00M | $502.00M | $518.00M | $532.00M | $1.49B |
Animal Healthsegment, Pharmaceuticalsegment were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
D&A at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s d&a?
- Merck & Co. (MRK) reported d&a of $1.49B in Q4 2025.
- How has Merck & Co.'s d&a changed year-over-year?
- Merck & Co.'s d&a increased by 186.0% year-over-year, from $522.00M to $1.49B.
- What is the long-term trend for Merck & Co.'s d&a?
- Over 4 years (2021 to 2025), Merck & Co.'s d&a has grown at a 17.9% compound annual growth rate (CAGR), from $1.58B to $3.05B.
- What does d&a mean?
- The accounting process of spreading the cost of physical and intangible assets over time.